Extracellular Signal Regulated Kinase 2 (ERK2)

[Edit]

MAPK1; P38; P40; ERK2; ERT1; MAPK2; P42MAPK; P42-MAPK; PRKM1; PRKM2; P41; P41mapk; P41-mapk; Mitogen-Activated Protein Kinase 1; Mitogen-activated protein kinase 2

Extracellular Signal Regulated Kinase 2 (ERK2)

Mitogen-activated protein kinase 1 also known as MAPK1, p42MAPK, and ERK2is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development.

The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA930Hu01 Recombinant Extracellular Signal Regulated Kinase 2 (ERK2) Positive Control; Immunogen; SDS-PAGE; WB.
APA930Hu01 Active Extracellular Signal Regulated Kinase 2 (ERK2) Cell culture; Activity Assays.
RPA930Hu02 Recombinant Extracellular Signal Regulated Kinase 2 (ERK2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA930Hu01 Polyclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
MAA930Hu22 Monoclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC
CAA930Hu22 Anti-Extracellular Signal Regulated Kinase 2 (ERK2) Monoclonal Antibody Loading Control of WB
CAA930Hu01 Anti-Extracellular Signal Regulated Kinase 2 (ERK2) Polyclonal Antibody Loading Control of WB
PAA930Hu02 Polyclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
MAA930Hu21 Monoclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
MAA930Hu23 Monoclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
MAA930Hu24 Monoclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
MAA930Hu25 Monoclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
Assay Kits SEA930Hu ELISA Kit for Extracellular Signal Regulated Kinase 2 (ERK2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Extracellular Signal Regulated Kinase 2 (ERK2) Recombinant Protein Customized Service Offer
Antibodies PAA930Mu01 Polyclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
CAA930Mi22 Anti-Extracellular Signal Regulated Kinase 2 (ERK2) Monoclonal Antibody Loading Control of WB
Assay Kits n/a CLIA Kit for Extracellular Signal Regulated Kinase 2 (ERK2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Extracellular Signal Regulated Kinase 2 (ERK2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA930Ra01 Recombinant Extracellular Signal Regulated Kinase 2 (ERK2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA930Ra01 Polyclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
MAA930Ra21 Monoclonal Antibody to Extracellular Signal Regulated Kinase 2 (ERK2) WB; IHC; ICC; IP.
CAA930Mi22 Anti-Extracellular Signal Regulated Kinase 2 (ERK2) Monoclonal Antibody Loading Control of WB
Assay Kits SEA930Ra ELISA Kit for Extracellular Signal Regulated Kinase 2 (ERK2) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Extracellular signal-regulated kinases in T cells: characterization of human ERK1 and ERK2 cDNAs."Biochem. Biophys. Res. Commun. 182:1416-1422(1992) [PubMed] [Europe PMC] [Abstract]
  2. "Heterogeneous expression of four MAP kinase isoforms in human tissues."FEBS Lett. 304:170-178(1992) [PubMed] [Europe PMC] [Abstract]
  3. "The DNA sequence of human chromosome 22." Nature 402:489-495(1999) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides."Nat. Biotechnol. 21:566-569(2003) [PubMed] [Europe PMC] [Abstract]
  6. "ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation."EMBO J. 14:4781-4793(1995) [PubMed] [Europe PMC] [Abstract]
  7. "3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region." Mol. Cell. Biol. 16:868-876(1996) [PubMed] [Europe PMC] [Abstract]
  8. "Human immunodeficiency virus type 1 Nef binds directly to LCK and mitogen-activated protein kinase, inhibiting kinase activity."J. Virol. 70:6701-6708(1996) [PubMed] [Europe PMC] [Abstract]
  9. "MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase."Biochem. Biophys. Res. Commun. 243:492-496(1998) [PubMed] [Europe PMC] [Abstract]
  10. "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB."EMBO J. 17:4426-4441(1998) [PubMed] [Europe PMC] [Abstract]
  11. "Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor."Genes Dev. 12:1953-1961(1998) [PubMed] [Europe PMC] [Abstract]
  12. "Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase."Science 280:1262-1265(1998) [PubMed] [Europe PMC] [Abstract]
  13. "Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway."J. Biol. Chem. 274:13271-13280(1999) [PubMed] [Europe PMC] [Abstract]
  14. "ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry."Oncogene 18:7948-7957(1999) [PubMed] [Europe PMC] [Abstract]
  15. "Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation."Science 286:2514-2517(1999) [PubMed] [Europe PMC] [Abstract]
  16. "The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells."Mol. Cell. Biol. 21:743-754(2001) [PubMed] [Europe PMC] [Abstract]
  17. "Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38."EMBO J. 21:3782-3793(2002) [PubMed] [Europe PMC] [Abstract]
  18. "IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation."EMBO J. 21:5151-5163(2002) [PubMed] [Europe PMC] [Abstract]
  19. "Insulin receptor substrate 4 associates with the protein IRAS."J. Biol. Chem. 277:19439-19447(2002) [PubMed] [Europe PMC] [Abstract]
  20. "EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2."Biol. Chem. 384:1215-1226(2003) [PubMed] [Europe PMC] [Abstract]
  21. "Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446."J. Biol. Chem. 278:32448-32456(2003) [PubMed] [Europe PMC] [Abstract]
  22. "Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK."Nat. Cell Biol. 5:647-654(2003) [PubMed] [Europe PMC] [Abstract]
  23. "Nek2A specifies the centrosomal localization of Erk2."Biochem. Biophys. Res. Commun. 321:495-501(2004) [PubMed] [Europe PMC] [Abstract]
  24. "Signal transduction via the stem cell factor receptor/c-Kit."Cell. Mol. Life Sci. 61:2535-2548(2004) [PubMed] [Europe PMC] [Abstract]
  25. "Extracellular signal-regulated kinase activated by epidermal growth factor and cell adhesion interacts with and phosphorylates vinexin."J. Biol. Chem. 279:34570-34577(2004) [PubMed] [Europe PMC] [Abstract]
  26. "MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol."Oncogene 23:5301-5315(2004) [PubMed] [Europe PMC] [Abstract]
  27. "Phosphorylation of Grb10 by mitogen-activated protein kinase: identification of Ser150 and Ser476 of human Grb10zeta as major phosphorylation sites."Biochemistry 44:8890-8897(2005) [PubMed] [Europe PMC] [Abstract]
  28. "Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK."EMBO J. 24:294-304(2005) [PubMed] [Europe PMC] [Abstract]
  29. "Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death."J. Biol. Chem. 280:21256-21263(2005) [PubMed] [Europe PMC] [Abstract]
  30. "Regulation of Raf-1 by direct feedback phosphorylation."Mol. Cell 17:215-224(2005) [PubMed] [Europe PMC] [Abstract]
  31. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  32. "ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA."Biochem. Biophys. Res. Commun. 368:162-167(2008) [PubMed] [Europe PMC] [Abstract]
  33. "Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26."Mol. Cell. Biol. 26:3282-3294(2006) [PubMed] [Europe PMC] [Abstract]
  34. "ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation."FEBS Lett. 581:727-734(2007) [PubMed] [Europe PMC] [Abstract]
  35. "Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs."Biochem. J. 413:51-60(2008) [PubMed] [Europe PMC] [Abstract]
  36. "Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma."Mol. Cancer Res. 6:383-394(2008) [PubMed] [Europe PMC] [Abstract]
  37. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
  38. "Identification and characterization of a general nuclear translocation signal in signaling proteins."Mol. Cell 31:850-861(2008) [PubMed] [Europe PMC] [Abstract]
  39. "Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction."Mol. Cell. Biol. 28:6954-6966(2008) [PubMed] [Europe PMC] [Abstract]
  40. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  41. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
  42. "Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling."Cell 139:610-622(2009) [PubMed] [Europe PMC] [Abstract]
  43. "The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction."J. Biol. Chem. 284:11039-11047(2009) [PubMed] [Europe PMC] [Abstract]
  44. "Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases."J. Biol. Chem. 284:22048-22058(2009) [PubMed] [Europe PMC] [Abstract]
  45. "Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration."J. Hepatol. 51:67-76(2009) [PubMed] [Europe PMC] [Abstract]
  46. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  47. "A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy."Nat. Med. 15:75-83(2009) [PubMed] [Europe PMC] [Abstract]
  48. "The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions."Growth Factors 24:21-44(2006) [PubMed] [Europe PMC] [Abstract]
  49. "The ERK signaling cascade--views from different subcellular compartments."BioFactors 35:407-416(2009) [PubMed] [Europe PMC] [Abstract]
  50. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  51. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  52. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  53. "The ERK cascade: distinct functions within various subcellular organelles."Genes Cancer 2:195-209(2011) [PubMed] [Europe PMC] [Abstract]
  54. "Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover."J. Biol. Chem. 286:44403-44411(2011) [PubMed] [Europe PMC] [Abstract]
  55. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  56. "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]
  57. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  58. "Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2."Proc. Natl. Acad. Sci. U.S.A. 110:E2934-2943(2013) [PubMed] [Europe PMC] [Abstract]
  59. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  60. "A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase."Protein Sci. 7:2249-2255(1998) [PubMed] [Europe PMC] [Abstract]
  61. "Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex."Biochem. Biophys. Res. Commun. 336:357-363(2005) [PubMed] [Europe PMC] [Abstract]
  62. "Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivative."Bioorg. Med. Chem. Lett. 16:55-58(2006) [PubMed] [Europe PMC] [Abstract]
  63. "Role of a cysteine residue in the active site of ERK and the MAPKK family."Biochem. Biophys. Res. Commun. 353:633-637(2007) [PubMed] [Europe PMC] [Abstract]
  64. "Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors."J. Med. Chem. 50:1280-1287(2007) [PubMed] [Europe PMC] [Abstract]
  65. "Structural basis of substrate recognition by hematopoietic tyrosine phosphatase."Biochemistry 47:13336-13345(2008) [PubMed] [Europe PMC] [Abstract]
  66. "Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control." J. Med. Chem. 52:6362-6368(2009) [PubMed] [Europe PMC] [Abstract]